Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤
基本信息
- 批准号:8557968
- 负责人:
- 金额:$ 70.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Amino Acid SequenceApoptosisAspergillus fumigatusAttenuatedBacteriaBacterial InfectionsCSF3 geneCathepsin CCathepsin GChronic Granulomatous DiseaseCysteine ProteaseCytoplasmic GranulesDisease modelEnzymesEpitheliumEscherichia coliGenesGlycoproteinsGranulocyte Colony-Stimulating FactorHematopoieticHost DefenseHumanImmuneIn VitroInfectionInflammationInflammatory Bowel DiseasesInterferonsIntraperitoneal InjectionsLaboratoriesLeukocyte ElastaseLifeLinkLungMalignant NeoplasmsMediatingMucous MembraneMusMutationMycosesMyelogenousNADPH OxidaseNatural ImmunityNoelin-1PatientsPeptide HydrolasesPeptide Sequence DeterminationPlayProcessProteinase 3ProteinsRecurrenceRegulationRelative (related person)ReportingResearchResistanceRoleSepsisSerine ProteaseStaphylococcus aureusTranslationsTretinoinalpha-latrotoxin receptorbactericidegastrointestinal infectionin vitro activityin vivokillingsneutrophilolfactomedinprecursor cellsuperoxide-generating NADPH oxidase
项目摘要
Olfactomedin 4 modulates neutrophil killing of S. aureus and E. coli in mice through inhibiting cathepsin C-mediated protease activities
Neutrophils kill bacteria generally through oxidative and nonoxidative mechanisms. Whereas much research has focused on the enzymes essential for neutrophil killing, little is known about the regulatory molecules responsible for such killing. In this study we investigated the role of olfactomedin 4 (OLFM4), an olfactomedin-related glycoprotein, in neutrophil bactericidal capability and host innate immunity. Neutrophils from
OLFM4-/- mice have increased intracellular killing of Staphylococcus aureus and Escherichia coli in vitro. The OLFM4-/- mice have enhanced in vivo bacterial clearance and are more resistant to sepsis when challenged with S. aureus or E. coli by intraperitoneal injection. OLFM4 was found to interact with cathepsin C, a cysteine protease that plays an important role in bacterial killing and immune regulation. We demonstrated that OLFM4 inhibited cathepsin C activity in vitro and in vivo. The cathepsin C activity in neutrophils from OLFM4-/- mice was significantly higher than that in neutrophils from wild-type littermate mice. The activities of three serine proteases (neutrophil elastase, cathepsin G, and proteinase 3), which require cathepsin C activity for processing and maturity, were also significantly higher in OLFM4-/- neutrophils. The bacterial killing and clearance capabilities observed in OLFM4-/- mice that was enhanced relative to WT mice was significantly compromised by the additional loss of cathepsin C in mice with OLFM4 and cathepsin C double deficiency. These results indicate that OLFM4 is an important negative regulator of neutrophil bactericidal activity by restricting cathepsin C activity and its downstream granule-associated serine proteases.
Deletion of OLFM4 Rescues Defective Host Defense Against Staphylococcus aureus, but not Aspergillus fumigatus in Murine X-linked Chronic Granulomatous Disease
Chronic granulomatous disease (CGD) patients have recurrent life-threating bacterial and fungal infections due to the mutation of one of four subunits of the respiratory burst oxidase (NADPH-oxidase). Olfactomedin 4 (OLFM4) is a neutrophil granule protein that negatively regulates host defense against bacteria infection. We aimed to evaluate the impact of OLFM4 deletion on host defense against Staphylococcus aureus and Aspergillus fumigatus in a murine X-linked CGD model. We found that intracellular killings as well as in vivo clearance of S. aureus, and resistance to S. aureus sepsis were significantly increased in gp91phox-and OLFM4-double deficient mice compared with CGD mice. However, double deficiency had no effect on host defense against pulmonary infection by A. fumigatus. These results show that OLFM4 deletion can successfully rescue immune deficiency against S. aureus, but not A. fumigatus in CGD mice. OLFM4 might prove to be an important target in CGD patients to augment host defense against bacterial infection.
Olfactomedin 4通过抑制组织蛋白酶c介导的蛋白酶活性调节小鼠对金黄色葡萄球菌和大肠杆菌的中性粒细胞杀伤
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GRIFFIN RODGERS其他文献
GRIFFIN RODGERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GRIFFIN RODGERS', 18)}}的其他基金
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
- 批准号:
8557970 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
- 批准号:
8939812 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Glia maturation factor-gamma negatively modulates TLR4 signaling in macrophages
胶质细胞成熟因子-γ负调节巨噬细胞中的 TLR4 信号传导
- 批准号:
8149534 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Recombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr
与 GATA1 融合的重组红系 Kruppel 样因子上调珠蛋白 expr
- 批准号:
8149535 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
- 批准号:
9157363 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Olfactomedin 4 down-regulates neutrophil killing of Gram-positive and Gram-negat
Olfactomedin 4 下调中性粒细胞对革兰氏阳性菌和革兰氏阴性菌的杀伤
- 批准号:
8344821 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
- 批准号:
8557967 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
Olfactomedin 4 通过 Negativ 抑制前列腺癌细胞的生长和转移
- 批准号:
8939810 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Glia maturation factor-gamma modulation of signaling pathways in macrophages
巨噬细胞信号通路的神经胶质成熟因子-γ调节
- 批准号:
9357228 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
Olfactomedin 4 is a key regulator of human neutrophil function
Olfactomedin 4 是人类中性粒细胞功能的关键调节剂
- 批准号:
10012677 - 财政年份:
- 资助金额:
$ 70.74万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 70.74万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 70.74万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 70.74万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 70.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 70.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 70.74万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 70.74万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 70.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 70.74万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 70.74万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




